22157.jpg
Global Senolytic Drugs Market Research Report 2022: Voice of Customer, Clinical Trials, Patent Analysis, Outlook, Market Dynamics, Trends & Developments, Competitive Landscape
May 20, 2022 05:13 ET | Research and Markets
Dublin, May 20, 2022 (GLOBE NEWSWIRE) -- The "Global Senolytic Drugs Market, By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib &...
Merck Recognized for Responsible Entrepreneurship in the Netherlands
May 19, 2022 15:39 ET | Embassy of the Kingdom of the Netherlands
Washington, D.C., May 19, 2022 (GLOBE NEWSWIRE) -- On May 19, the Embassy of the Kingdom of the Netherlands presented the 2022 Holland on the Hill Heineken Award to New Jersey-based...
clarus_final_indentity.jpg
Clarus Therapeutics Announces Issuance of Patent Covering JATENZO® (testosterone undecanoate)
May 18, 2022 09:05 ET | Clarus Therapeutics Holdings, Inc.
JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions Clarus plans to list this patent...
YSEOP_LOGO_FINAL-PURPLE-_-YELLOW (1).png
Yseop’s AI-Powered Augmented Analyst Chosen by Lilly to Expedite the Drug Approval Process and Deploy Automation at Scale
May 18, 2022 08:00 ET | Yseop
NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- Yseop, a world-leading AI software company and pioneer in Natural Language Processing (NLP), today announced a strategic collaboration with Eli Lilly and...
AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell & Gene Hub
May 17, 2022 22:03 ET | AGC Biologics
SEATTLE, May 17, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it is adding viral vector...
BICX.jpg
BioCorRx Business Update for the First Quarter of 2022
May 17, 2022 08:30 ET | BioCorRx Inc
ANAHEIM, CA, May 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire  – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and...
22157.jpg
Global Polyclinics Market to 2027 - Featuring Optum, MCI Onehealth Technologies and Georgia Healthcare Among Others
May 17, 2022 05:03 ET | Research and Markets
Dublin, May 17, 2022 (GLOBE NEWSWIRE) -- The "Global Polyclinics Market, By Type (Large Scale Polyclinic v/s Express Clinic), By Services (Diagnostic, Consultation, Treatment), By Therapy Area, By...
lumos.png
Lumos Pharma to Participate in Upcoming Investor Conferences
May 16, 2022 16:05 ET | Lumos Pharma, Inc.
AUSTIN, Texas, May 16, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
clarus_final_indentity.jpg
Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results
May 16, 2022 16:05 ET | Clarus Therapeutics Holdings, Inc.
First quarter 2022 net revenue increased 72% year-over-year to $4.0 million First quarter 2022 total prescription growth for JATENZO® increased 12% sequentially and increased 75% year-over-year ...
Paul Mueller Company Logo
Paul Mueller Company Declares Quarterly Cash Dividend
May 13, 2022 18:00 ET | Paul Mueller Company
SPRINGFIELD, Mo., May 13, 2022 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced that its Board of Directors has declared a cash dividend of 15 cents ($0.15) per share on its...